Skip to content
March 28, 2024

Equity.Guru

Investment information for the new generation

Search

ACST.V

Acasti Pharma (ACST.V) announced today that it has initiated its planned pharmacokinetic (PK) bridging study to evaluate the bioavailability of intravenous (IV) GTX-104 compared to oral nimodipine capsules in…